|

Venetoclax in combination with fludarabine and melphalan Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • First Affiliated Hospital of Zhejiang University1

Indications

  • Myeldysplastic Syndrome (MDS)1
  • Acute Myeloid Leucemia1
  • ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION1
  • Conditioning1
  • Venentoclax1

Other1 trial

Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.